DE3177155D1 - Verwendung von 2-beta-d-ribofuranosylthiazol-4-carboxamiden zur herstellung von medikamenten zur behandlung von krebsartigen tumoren.
- Google Patents
Verwendung von 2-beta-d-ribofuranosylthiazol-4-carboxamiden zur herstellung von medikamenten zur behandlung von krebsartigen tumoren.
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viratek Inc
Original Assignee
Viratek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viratek IncfiledCriticalViratek Inc
Application grantedgrantedCritical
Publication of DE3177155D1publicationCriticalpatent/DE3177155D1/de
DE8181305874T1980-12-151981-12-14Verwendung von 2-beta-d-ribofuranosylthiazol-4-carboxamiden zur herstellung von medikamenten zur behandlung von krebsartigen tumoren.
Expired - LifetimeDE3177155D1
(de)